Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an ...

The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to Beckman Coulter Diagnostics' new DxC 500i Clinical ...

Ahomebrewbead-based immunoassay begins with the capture and labeling of an analyte using an enzyme conjugate (streptavidin ß-galactosidase, SBG). The analyte is captured with beads, and a ...

Thanks to predictive and preventive medicine. The global immunoassay market is projected to grow by $8.64b until 2028 at a compound annual growth rate of 4.42%, said Technavio. The sector’s ...

NEW YORK – Danaher subsidiary Beckman Coulter Diagnostics announced on Monday that its integrated clinical chemistry and immunoassay analyzer has received 510 (k) clearance from the US Food and Drug ...

With throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay tests per hour, this analyzer delivers precise and reliable results critical for timely clinical decision-making.

Beckman Coulter Diagnostics announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, ...